Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. by Küker, W, Nägele, T, Thiel, E, Weller, M, Herrlinger, U

Primary CNS lymphoma: Diagnosis and treatment by Herrlinger, U, Plasswilm, L, Deckert, M, Küker, W, Thiel, E

Peptide vaccination induces specific effector and memory T cells but fails to enhance preexisting T cell immunity by Thiel E, Asemissen AM, Nagorsen D, Keilholz U, Letsch A, Scheibenbogen C

Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study by Llanos JP, Bell CF, Packnett E, Thiel E, Irwin DE, Hahn B, Ortega H

Get full text

Addition of histamine to IL-2 treatment augments T1 cell-function in melanoma patients <it>in vivo</it>: results from a randomized clinical trial of IL-2 with or without histamine... by Gehlsen K, Thiel E, Hellstrand K, Letsch A, Scheibenbogen C, Asemissen AM, Keilholz U

Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. by Küker, W, Nägele, T, Korfel, A, Heckl, S, Thiel, E, Bamberg, M, Weller, M, Herrlinger, U

Primary central nervous system (CNS) lymphoma in immunocompetent patients. by Plasswilm, L, Herrlinger, U, Korfel, A, Weller, M, Küker, W, Kanz, L, Thiel, E, Bamberg, M